Evidence map›Paper›PMID 35392427›Full record

ArticleRheumatology advances in practice2022

The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey.

Kristen Young, Su-Ann Yeoh, Michael Putman, Sebastian Sattui, Richard Conway, Elizabeth Graef, Adam Kilian, Maximilian Konig, Jeffrey Sparks, Manuel Ugarte-Gil and 14 more

Open access · goldAbstract read
In one paragraph

Article in Rheumatology advances in practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 8 countries.

Kristen YoungDivision of Rheumatology, University of Arizona College of Medicine, Phoenix, AZ, USA.ORCID https://orcid.org/0000-0001-8570-2228
Su-Ann YeohDepartment of Rheumatology, University College London, London, UK.ORCID https://orcid.org/0000-0002-4692-4669
Michael PutmanDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID https://orcid.org/0000-0001-9699-4000
Sebastian SattuiDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID https://orcid.org/0000-0002-3945-6828
Richard ConwayDepartment of Rheumatology, St James's Hospital, Dublin, Ireland.ORCID https://orcid.org/0000-0003-2538-3362
Elizabeth GraefRheumatology Division, Boston University, Boston, MA.
Adam KilianDivision of Rheumatology, Saint Louis University School of Medicine, St. Louis, MO.
Maximilian KonigDivision of Rheumatology, Johns Hopkins University, Baltimore, MD.ORCID https://orcid.org/0000-0001-5045-5255
Jeffrey SparksDivision of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-5556-4618
Manuel Ugarte-GilRheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud.ORCID https://orcid.org/0000-0003-1728-1999
Laura UptonDivision of Dermatology, Saint Louis University School of Medicine, St Louis, MO, USA.
Francis BerenbaumDepartment of Rheumatology, Hopital Saint-Antoine, Paris, France.
Suleman BhanaUS Medical Affairs, Pfizer Inc, New York, NY, USA.
Wendy CostelloIrish Children's Arthritis Network, Tipperary, Ireland.
Jonathan HausmannRheumatology, Boston Children's Hospital, Boston, MA, USA.
Pedro MachadoDepartment of Rheumatology, University College London, London, UK.ORCID https://orcid.org/0000-0002-8411-7972
Philip RobinsonSchool of Clinical Medicine, University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0002-3156-3418
Emily SirotichCanadian Arthritis Patient Alliance, McMaster University, Hamilton, ON, Canada.
Paul SufkaDepartment of Rheumatology, HealthPartners, St. Paul, MN.
Jinoos YazdanyDivision of Rheumatology, University of California in San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-3508-4094
Jean LiewRheumatology Division, Boston University, Boston, MA.ORCID https://orcid.org/0000-0002-8104-2450
Rebecca GraingerDepartment of Medicine, University of Otago, Wellington, New Zealand.ORCID https://orcid.org/0000-0001-9201-8678
Zachary WallaceDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
Arundathi JayatillekeRheumatology, School of Medicine, Temple University, Philadelphia, PA, USA.
Boston University · USSaint Louis University · USUniversity College London · GBBoston Children's Hospital · USBrigham and Women's Hospital · USCanadian Arthritis Patient Alliance · CAHealthPartners · USJohns Hopkins University · USMassachusetts General Hospital · USMedical College of Wisconsin · USPfizer (United States) · USSorbonne Université · FRSt. James's Hospital · IETemple University · USThe University of Queensland · AUUniversidad Científica del Sur · PEUniversity of Arizona · USUniversity of California, San Francisco · USUniversity of Otago · NZUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim was to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on the clinical experiences, research opportunities and well-being of rheumatology trainees. Methods: A voluntary, anonymous, Web-based survey was administered in English, Spanish or French from 19 August 2020 to 5 October 2020. Adult and paediatric rheumatology trainees were invited to participate via social media and email. Using multiple-choice questions and Likert scales, the perceptions of trainees regarding the impact of the COVID-19 pandemic on patient care and redeployment, learning and supervision, research and well-being were assessed. Results: There were 302 respondents from 33 countries, with 83% in adult rheumatology training. An increase in non-rheumatology clinical work was reported by 45%, with 68% of these having been redeployed to COVID-19. Overall, trainees reported a negative impact on their learning opportunities during rheumatology training, including outpatient clinics (79%), inpatient consultations (59%), didactic teaching (55%), procedures (53%), teaching opportunities (52%) and ultrasonography (36%). Impacts on research experiences were reported by 46% of respondents, with 39% of these reporting that COVID-19 negatively affected their ability to continue their pre-pandemic research. Burnout and increases in stress were reported by 50% and 68%, respectively. Physical health was negatively impacted by training programme changes in 25% of respondents. Conclusion: The COVID-19 pandemic has had a substantial impact on rheumatology training and trainee well-being. Our study highlights the extent of this impact on research opportunities and clinical care, which are highly relevant to future curriculum planning and the clinical learning environment.

Indexed as

COVID-19Medical EducationRheumatology Fellowship

Identifiers

PMID35392427
PMCPMC8982766
OpenAlexW4226277062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.